![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/48 | |
A61K 38/36 | |||
A61K 45/06 | |||
A61K 9/22 | |||
A61P 3/10 |
(11) | Number of the document | 2437732 |
(13) | Kind of document | T |
(96) | European patent application number | 10784223.9 |
Date of filing the European patent application | 2010-06-07 | |
(97) | Date of publication of the European application | 2012-04-11 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/037605 |
Date | 2010-06-07 |
(87) | Number | WO 2010/141938 |
Date | 2010-12-09 |
(30) | Number | Date | Country code |
217906 P | 2009-06-05 | US |
(72) |
CINCOTTA, Anthony, H., US
|
(73) |
VeroScience LLC,
1334 Main Road, Tiverton RI 02878,
US
|
(54) | COMBINATION OF DOPAMINE AGONISTS PLUS FIRST PHASE INSULIN SECRETAGOUGES FOR THE TREATMENT OF METABOLIC DISORDERS |
COMBINATION OF DOPAMINE AGONISTS PLUS FIRST PHASE INSULIN SECRETAGOUGES FOR THE TREATMENT OF METABOLIC DISORDERS |